2018 US Tumor Marker Testing Market Shares, Segmentation Forecasts, Competitive Landscape, Innovative Technologies, Latest Instrumentation, Opportunities for Suppliers

News provided by

Sep 20, 2018, 15:35 ET

LONDON, Sept. 20, 2018
/PRNewswire/ -- Highlights

Comprehensive 620-page analysis of the US tumor marker testing market.
Major issues pertaining to the US laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next five years.
Mortality statistics and scientific views on the etiology of major types of cancer, e.g., lung, colorectal, breast, prostatic, pancreatic, leukemia, lymphoma, gastrointestinal, bladder, liver, ovarian, testicular, oral, skin and others.
Five-year test volume and sales forecasts over for 40 tumor marker performed in US hospitals, commercial laboratories and physician offices.
Placements and installed base of automated and semi-automated analyzers used for tumor marker testing.
Current instrumentation technologies and feature comparison of leading analyzers.
Sales and market shares of leading suppliers.
Emerging diagnostic technologies and their potential market applications.
Product development opportunities.
Profiles of current and emerging suppliers, including their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in RandD, collaborative arrangements and business strategies.
Business opportunities and strategic recommendations for suppliers.

Contains 620 pages and 103 tables

Download the full report: https://www.reportbuyer.com/product/5568640

About Reportbuyer
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: [email protected]
Tel: +1 (718) 213 4904
Website: www.reportbuyer.com

SOURCE ReportBuyer

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

GET STARTED